The Study
Long-term retreatment outcomes after definitive management of Graves' disease with radioactive iodine versus surgery.
This study looked at people who already got either surgery or radioactive iodine for their thyroid and saw who needed more treatment later. It doesn't prove one is better — it just shows a pattern, like noticing that kids who eat apples seem to get fewer colds, but maybe they also wash their hands more.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
Doctors compared two ways to treat an overactive thyroid: cutting out the thyroid (surgery) or using radioactive iodine to destroy it. They followed patients for years to see who stayed healthy.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 550 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Surgery led to much more lasting results — most people didn’t need more treatment later, while many who got radioactive iodine needed another round of treatment.
- 2After 6 months, 99% of surgery patients were cured, but only 69% of radioactive iodine patients were.
- 3Of those who initially improved with radioactive iodine, 19% got sick again later.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Surgery
Year
2024
Authors
Emily A. Engelbrecht-Wiggans, Kendyl M Carlisle, Elvina Yunasan, Caleb Fan, K. Munir, Julia H Terhune, Douglas J. Turner, Yinin Hu
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.